Speaker sees little value in use of NSAIDs for dry eye, corneal melt

NEW ORLEANS — While NSAIDs may be useful for treating corneal transplant rejection, they should not be used in dry eyes or cases of corneal melt, a speaker said here. Graft rejection detected early in a low-risk patient may be reversible in 75% of cases, Reza Dana, MD, said at Cornea Subspecialty Day preceding the American Academy of Ophthalmology meeting.“Our current approach in patients at high risk of rejection (three or more quadrants of neovascularization) is we prophylax intraoperatively with subconjunctival and intravenous steroid, then 3 to 6 weeks of (Read more...)

Full Story →